Resultados de la búsqueda 1271-1280 of 16101 for non celiac gluten sensitivity

  1. Ensayos clínicos - Neurología

    ... no approved treatments or cures. The study has ... Electrophysiological Biomarkers for Parkinson's Disease ... This study will determine the validity of predictive ...

  2. Neurología - Ensayos clínicos

    Jacksonville, Fla. The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an ...

  3. Ensayos clínicos - Neurología

    Blood and Spinal Fluid Collection for Research Studies in Motor Neuron Disease and Motor Neuropathy. Rochester, Minn. The purpose of this study is so that blood ...

  4. Ensayos clínicos - Neurología

    The purpose of this study is to monitor outcome to ensure that children and young adults with localized central nervous system (CNS) non-germinomatous germ ...

  5. Ensayos clínicos - Neurología

    Evaluating Optic Nerve Disease with OCT Angiography. Rochester, Minn. The purpose of this study is to determine if optical coherence tomography (OCT) ...

  6. Dermatología - Ensayos clínicos

    Este contenido no tiene una versión en inglés ... disease cohort, both across and within tumor biomarker subgroups. ... Aviso sobre no discriminación · Declaración ...

  7. Hemocromatosis - Atención en Mayo Clinic

    With 13 specialty groups and more than 140 digestive disease ... Having all this expertise in a single place, focused on you, means that you're not just getting ...

  8. Cómo el mapeo cerebral mejora la cirugía de cerebro - Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet. Aug. 20, 2024 ...

  9. Ensayos clínicos - Neurología

    The purpose of this study is to collect blood samples for DNA analysis from patients clinically diagnosed with Alzheimers disease, Lewy Body disease, and ...

  10. Centro Pediátrico de Mayo Clinic

    Rochester, Minn. 90 genes related to Monogenic Stone Disease will be determined via DNA analysis by the Mayo Rare Kidney Stone Consortium (RKSC) research staff.